Development of Inactivated FAKHRAVAC(®) Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models

The recent viral infection disease pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global public health crisis. Iran, as one of the countries that reported over five million infected cases by September 2021, has been concerned with the urgent devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghasemi, Soheil, Naderi Saffar, Kosar, Ebrahimi, Firooz, Khatami, Pezhman, Monazah, Arina, Alizadeh, Ghorban-Ali, Ettehadi, Hossein-Ali, Rad, Iman, Nojehdehi, Shahrzad, Kehtari, Mousa, Kouhkan, Fatemeh, Barjasteh, Hesam, Moradi, Sohrab, Ghorbani, Mohammad-Hosein, Khodaie, Ali, Papizadeh, Moslem, Najafi, Roghayeh, Naghneh, Ehsan, Sadeghi, Davood, Karimi Rahjerdi, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622747/
https://www.ncbi.nlm.nih.gov/pubmed/34835202
http://dx.doi.org/10.3390/vaccines9111271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622747/
https://www.ncbi.nlm.nih.gov/pubmed/34835202
http://dx.doi.org/10.3390/vaccines9111271

Ejemplares similares